Toggle navigation
Home
Search
Services
Blog
Contact
About
Design/Synthesis of Oral Galanin Agonists/Antagonists
Wolff, Manfred E.
Immunopharmaceutics, Inc., San Diego, CA, United States
Search 3 grants from Manfred Wolff
Search grants from Immunopharmaceutics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Food Protection Task Force Conference
Federal Employment Information and Services
AMP: The Mid-South Alliance for Minority Participation
Electromagnetic Field Enhancement of Membrane Ion Transport Research Initiation Award
Reciprocal Interactions Between Herbivores and Plant Pathogens on Cottonwood (Biotic Systems and Resources)
Recently added grants:
Regulatory Mechanisms of Cardiomyocyte Lineage Specification
Optimizing Physical Activity Outcomes for Veterans After Total Knee Arthroplasty
Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation
Novel Innate Mechanisms of Immune Tolerance Induction in Allogeneic Hct for Hemoglobinopathies
Investigating the role of cell-mediated collagen turnover in regulating tissue fibrosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43MH030021-000
Application #
3667506
Study Section
Project Start
1993-09-01
Project End
Budget Start
1993-09-01
Budget End
1994-02-28
Support Year
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
Immunopharmaceutics, Inc.
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92127
Related projects
NIH 1994
N43 MH
Design/Synthesis of Oral Galanin Agonists/Antagonists
Manfred, Wolff / Immunopharmaceutics, Inc.
NIH 1993
N43 MH
Design/Synthesis of Oral Galanin Agonists/Antagonists
Wolff, Manfred E. / Immunopharmaceutics, Inc.
Comments
Be the first to comment on Manfred Wolff's grant